Back to Journals » Drug Design, Development and Therapy » Volume 15

A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy

Total article views   HTML views PDF downloads Totals
4,696 Dovepress* 4,283+ 212 4,495
PubMed Central* 413 189 602
Totals 4,696 401 5,097
*Since 16 November 2021

View citations on PubMed Central and Google Scholar